AcceleVation: BofA Global Research initiates coverage with buy rating and $20 price objective
ACCV•BofA Global Research initiated coverage of AcceleVation with a buy rating and a $20 price objective.
ACCV•ACCV•ACCV•BofA Global Research initiated coverage of AcceleVation with a buy rating and a $20 price objective.
